Mostrar el registro sencillo del ítem
Mechanisms of cross resistance between cisplatin and bleomycin in saccharomyces cerevisiae
dc.contributor.author | Burgos-Molina, Antonio Manuel | |
dc.contributor.author | Gil-Carmona, Luisa | |
dc.contributor.author | Ruiz-Gómez, Miguel José | |
dc.date.accessioned | 2019-01-16T12:39:22Z | |
dc.date.available | 2019-01-16T12:39:22Z | |
dc.date.created | 2018 | |
dc.date.issued | 2019-01-16 | |
dc.identifier.uri | https://hdl.handle.net/10630/17164 | |
dc.description.abstract | Tumor cells can simultaneously acquire resistance against a diverse group of drugs. This phenomenon is called pleotropic resistance or multidrug resistance. This mechanism could explain the tumor resistance observed in chemotherapy treatments with multiple agents. The aim of this work is to study possible mechanisms of cross resistance between Cisplatin and Bleomycin in Saccharomyces cerevisiae. | en_US |
dc.description.sponsorship | Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech. | en_US |
dc.language.iso | eng | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Bleomicina | en_US |
dc.subject | Tumores | en_US |
dc.subject.other | Cisplatin | en_US |
dc.subject.other | Bleomycin | en_US |
dc.subject.other | Mechanisms of cross resistance | en_US |
dc.title | Mechanisms of cross resistance between cisplatin and bleomycin in saccharomyces cerevisiae | en_US |
dc.type | info:eu-repo/semantics/conferenceObject | en_US |
dc.centro | Facultad de Medicina | en_US |
dc.relation.eventtitle | 16th ASEICA International Congress 2018 | en_US |
dc.relation.eventplace | Valencia (España) | en_US |
dc.relation.eventdate | 06-08/11/2018 | en_US |
dc.rights.cc | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.departamento | Especialidades Quirúrgicas, Bioquímica e Inmunología |